69É«ÇéƬ

A research study produced by 69É«ÇéƬ and King’s College London suggests that genetic predisposition significantly contributes to risk prediction for multifactorial diseases such as breast cancer and coronary artery disease above and beyond typical underwriting risk fac... Read More

69É«ÇéƬ is ready to help you expand your current distribution toolset. Contact us to explore product innovations from around the world. Read More

Bancassurance is digitizing in South Africa and around the world. 69É«ÇéƬ conducted a survey of the largest bancassurers in that country. Get the highlights in our easy infographic.
Read More

Insurers require more than raw information from partners – they need interpretation, innovation, and collaboration to create competitive advantage. More than 15 years ago, 69É«ÇéƬ established the Global Client Actuarial Seminar (GCAS) to serve as a source f... Read More

As the pandemic evolves, new evidence and data-driven insights will continue to emerge, which 69É«ÇéƬ will continue to investigate. Please  contact us for insights....

Read More

Robotic surgery (also known as robot-assisted surgery) is one of the fastest-growing specialties in surgical medicine today. In the past two decades, it has seen a steep rise in utilization, and today it is integral to several medical specialties. Ultimately, success...

Read More

Could COVID-19 stay with the world for months, if not years to come? 69É«ÇéƬ's Hilary Henly makes the case, and shares different factors insurers should consider for future product planning and pricing, underwriting, and in setting claims expectations.

As t...

Read More

Commissions create an incentive to sell, rather than collect accurate information, which could influence the application process. In addition, form designers have little control over how questions and clarifications are phrased by advisers in practice, which risks th...

Read More

At 69É«ÇéƬ, we are eager to speak with clients about any support needed as we confront the COVID-19 challenge together. Contact us to learn more about the resources, solutions, and services available.

Read More

The pandemic severely disrupted hospital services, particularly in the first half of 2020. As waiting lists for care have grown, 69É«ÇéƬ's Anna Currie wonders about morbidity and mortality impacts. She draws on major research by the Institute for Public Policy Research (IPP... Read More

This article presents key factors for insurers to consider when selecting a counterparty to reinsure life and annuity blocks in today’s market, including:

• Putting a price on counterparty credit risk...

Read More

Curious about 69É«ÇéƬ's medical insights?  Contact us&...

Read More

Curious about 69É«ÇéƬ's medical insights?  Contact us to learn m...

Read More

Curious about 69É«ÇéƬ's medical insights?  Contact us to learn m...

Read More

Facultative cases exist on a spectrum of difficulty, and increasingly, insurers recognize that many of these substandard submissions benefit from a blend of human judgment and automated processes – a hybrid approach. 69É«ÇéƬ's Scott Sibley explains.

Read More

From scorching heatwaves to extreme floods to melting glaciers, signs of climate change are inescapable. These extreme weather events pose a particularly vexing problem for life insurers.
Read More

The COVID-19 pandemic accelerated the use of digital distribution in life insurance. The bancassurance channel – with digitalization at the core of its operation – has the potential to build on this momentum. With the right approach, insurers can use banks’ proven distr... Read More

This article is the second in a three-part series, highlighting areas of research funded by the  (LLF), a not-for-profit organization that supports the study of scientific an...

Read More

FAC Console arrived in 2000 and launched a quiet revolution in facultative underwriting. Yet, like any utility after 20 years, FAC Console needed to evolve. It is now transitioning into the cloud as FAC Exchange.  Read More

As the pace of investigation and discovery in genetics continues to expand and accelerate, genetic and genomic testing is now playing an increasingly pivotal role in clinical medicine as well as in life and health insurance. Read More